MULTIFOCAL MOTOR NEUROPATHY (MMN)
Clinical trials for MULTIFOCAL MOTOR NEUROPATHY (MMN) explained in plain language.
Never miss a new study
Get alerted when new MULTIFOCAL MOTOR NEUROPATHY (MMN) trials appear
Sign up with your email to follow new studies for MULTIFOCAL MOTOR NEUROPATHY (MMN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune globulin drug shows promise for rare nerve diseases in japan
Disease control CompletedThis completed Phase 3 study tested TAK-771, a combination of immune globulin and hyaluronidase, in 26 Japanese adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) or multifocal motor neuropathy (MMN). The main goals were to check for side effects and see…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Blood test may Fine-Tune IVIg dosing for rare nerve disorders
Knowledge-focused CompletedThis study looked at 20 adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) or multifocal motor neuropathy (MMN) who were starting intravenous immunoglobulin (IVIg) treatment. Researchers measured changes in IgG levels in the blood after the first dose to…
Matched conditions: MULTIFOCAL MOTOR NEUROPATHY (MMN)
Sponsor: Walton Centre NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC